Literature DB >> 21640828

Expression and purification of 15N- and 13C-isotope labeled 40-residue human Alzheimer's β-amyloid peptide for NMR-based structural analysis.

Fei Long1, Wonhwa Cho, Yoshitaka Ishii.   

Abstract

Amyloid fibrils of Alzheimer's β-amyloid peptide (Aβ) are a primary component of amyloid plaques, a hallmark of n class="Disease">Alzheimer's disease (AD). Enormous attention has been given to the structural features and functions of Aβ in amyloid fibrils and other type of aggregates in associated with development of AD. This report describes an efficient protocol to express and purify high-quality 40-residue Aβ(1-40), the most abundant Aβ in brains, for structural studies by NMR spectroscopy. Over-expression of Aβ(1-40) with glutathione S-transferase (GST) tag connected by a Factor Xa recognition site (IEGR(▾)) in Escherichia coli resulted in the formation of insoluble inclusion bodies even with the soluble GST tag. This problem was resolved by efficient recovery of the GST-Aβ fusion protein from the inclusion bodies using 0.5% (w/v) sodium lauroyl sarcosinate as solubilizing agent and subsequent purification by affinity chromatography using a glutathione agarose column. The removal of the GST tag by Factor Xa enzymatic cleavage and purification by HPLC yielded as much as ∼7 mg and ∼1.5mg of unlabeled Aβ(1-40) and uniformly (15)N- and/or (13)C-protein Aβ(1-40) from 1L of the cell culture, respectively. Mass spectroscopy of unlabeled and labeled Aβ and (1)H/(15)N HSQC solution NMR spectrum of the obtained (15)N-labeled Aβ in the monomeric form confirmed the expression of native Aβ(1-40). It was also confirmed by electron micrography and solid-state NMR analysis that the purified Aβ(1-40) self-assembles into β-sheet rich amyloid fibrils. To the best of our knowledge, our protocol offers the highest yields among published protocols for production of recombinant Aβ(1-40) samples that are amendable for an NMR-based structural analysis. The protocol may be applied to efficient preparation of other amyloid-forming proteins and peptides that are (13)C- and (15)N-labeled for NMR experiments.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640828      PMCID: PMC3134129          DOI: 10.1016/j.pep.2011.05.012

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  44 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Expression and purification of a recombinant peptide from the Alzheimer's beta-amyloid protein for solid-state NMR.

Authors:  Simon Sharpe; Wai-Ming Yau; Robert Tycko
Journal:  Protein Expr Purif       Date:  2005-03-25       Impact factor: 1.650

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

4.  Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy.

Authors:  Neil A Whittemore; Rajesh Mishra; Indu Kheterpal; Angela D Williams; Ronald Wetzel; Engin H Serpersu
Journal:  Biochemistry       Date:  2005-03-22       Impact factor: 3.162

5.  Isotope labeling strategies for the study of high-molecular-weight proteins by solution NMR spectroscopy.

Authors:  Vitali Tugarinov; Voula Kanelis; Lewis E Kay
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.

Authors:  Liming Hou; Michael G Zagorski
Journal:  J Am Chem Soc       Date:  2006-07-26       Impact factor: 15.419

7.  Expression, purification, and characterization of recombinant human beta-amyloid42 peptide in Escherichia coli.

Authors:  Li Zhang; Huixin Yu; Cuicui Song; Xiufeng Lin; Bo Chen; Chen Tan; Guoxian Cao; Zhengwu Wang
Journal:  Protein Expr Purif       Date:  2008-11-01       Impact factor: 1.650

8.  Abeta40 protects non-toxic Abeta42 monomer from aggregation.

Authors:  Yilin Yan; Chunyu Wang
Journal:  J Mol Biol       Date:  2007-04-12       Impact factor: 5.469

9.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Authors:  A Lorenzo; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  A novel purification method for histidine-tagged proteins containing a thrombin cleavage site.

Authors:  M H Hefti; C J Van Vugt-Van der Toorn; R Dixon; J Vervoort
Journal:  Anal Biochem       Date:  2001-08-15       Impact factor: 3.365

View more
  5 in total

1.  Aggregation and Fibril Structure of AβM01-42 and Aβ1-42.

Authors:  Robert Silvers; Michael T Colvin; Kendra K Frederick; Angela C Jacavone; Susan Lindquist; Sara Linse; Robert G Griffin
Journal:  Biochemistry       Date:  2017-08-30       Impact factor: 3.162

2.  Highly efficient soluble expression, purification and characterization of recombinant Aβ42 from Escherichia coli.

Authors:  Longgang Jia; Wenjuan Wang; Jinzhao Shang; Wenping Zhao; Wei Wei; Ying Wang; Li Li; Fuping Lu; Fufeng Liu
Journal:  RSC Adv       Date:  2018-05-21       Impact factor: 4.036

3.  A Robust and Efficient Production and Purification Procedure of Recombinant Alzheimers Disease Methionine-Modified Amyloid-β Peptides.

Authors:  Marie Hoarau; Yannick Malbert; Romain Irague; Christelle Hureau; Peter Faller; Emmanuel Gras; Isabelle André; Magali Remaud-Siméon
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

4.  High-yield Production of Amyloid-β Peptide Enabled by a Customized Spider Silk Domain.

Authors:  Axel Abelein; Gefei Chen; Kristīne Kitoka; Rihards Aleksis; Filips Oleskovs; Médoune Sarr; Michael Landreh; Jens Pahnke; Kerstin Nordling; Nina Kronqvist; Kristaps Jaudzems; Anna Rising; Jan Johansson; Henrik Biverstål
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

5.  Bacterial expression strategies for several Sus scrofa diacylglycerol kinase alpha constructs: solubility challenges.

Authors:  Elizabeth J Petro; Daniel M Raben
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.